tiprankstipranks
Passage Bio (PASG)
NASDAQ:PASG
US Market
Holding PASG?
Track your performance easily

Passage Bio (PASG) Income Statement

447 Followers

Passage Bio Income Statement

Last quarter (Q3 2024), Passage Bio's total revenue was $332.00K, an increase of Infinity% from the same quarter last year. In Q3, Passage Bio's net income was $-19.34M. See Passage Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 575.00K----$ 0.00
Cost of Revenue
------
Gross Profit
$ 575.00K-----
Operating Expense
$ 73.98M$ 103.00M$ 135.39M$ 185.73M$ 112.90M$ 36.69M
Operating Income
$ -74.58M$ -108.39M$ -138.39M$ -185.73M$ -112.90M$ -36.69M
Net Non Operating Interest Income Expense
--$ -2.27M$ 343.00K$ 670.00K$ 696.00K
Other Income Expense
$ -6.86M$ 937.00K$ -731.00K$ -343.00K-$ -9.64M
Pretax Income
$ -68.78M$ -102.06M$ -136.13M$ -185.39M$ -112.23M$ -45.63M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -68.79M$ -102.06M$ -136.13M$ -185.39M$ -112.23M$ -45.63M
Basic EPS
$ -1.17$ -1.86$ -2.50$ -3.48$ -2.91$ -1.90
Diluted EPS
$ -1.17$ -1.86$ -2.50$ -3.48$ -2.91$ -1.90
Basic Average Shares
$ 234.62M$ 54.74M$ 54.43M$ 53.34M$ 38.62M$ 23.96M
Diluted Average Shares
$ 234.62M$ 54.74M$ 54.43M$ 53.34M$ 38.62M$ 23.96M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 73.98M$ 103.00M$ 135.39M$ 185.73M$ 112.90M$ 36.69M
Net Income From Continuing And Discontinued Operation
$ -68.80M$ -102.06M$ -136.13M$ -185.39M$ -112.23M$ -45.63M
Normalized Income
$ -56.67M$ -71.60M-$ -146.45M-$ -35.99M
Interest Expense
------
EBIT
$ -70.53M$ -103.00M$ -135.39M$ -177.73M$ -111.90M$ -36.69M
EBITDA
$ -68.48M$ -99.28M$ -131.72M$ -176.19M$ -111.10M$ -36.55M
Currency in USD

Passage Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis